Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;333 (12 August), doi:10.1136/bmj.333.7563.0-f
| The first 150 words of the full text of this article appear below. |
There's lots of clinical stuff in the BMJ this weekchosen because we think it will help doctors make better decisions.
From their randomised controlled trial of antibiotics for acute conjunctivitis, Everitt and colleagues (p 321) conclude that the best strategy is delayed prescribing (a prescription to be collected at the patient's discretion after three days). Remco Rietveld and colleagues conclude that withholding antibiotics for such minor complaints can be considered harmless in Western countries, where the incidence of complications has declined sharply in the past decades. Antibiotics may thus be reserved for more serious conditions, such as infective endocarditislinked nowadays in the West more to intravenous drug misuse, degenerative valve disease, and nosocomial infection than to rheumatic fever. Rhys Beynon and colleagues advocate a multidisciplinary approach in their clinical review (p 334).
Meanwhile there's good news for one old drug and bad news for another. Wallenborn
Fiona Godlee, editor
(fgodlee@bmj.com)